Loading clinical trials...
Loading clinical trials...
Pilot Study to Identify Biomarkers That May Predict Response to High Dose IL-2
Conditions
Interventions
aldesleukin
gene expression analysis
+2 more
Locations
1
United States
University of Nebraska Medical Center, Eppley Cancer Center
Omaha, Nebraska, United States
Start Date
October 2, 2007
Primary Completion Date
February 18, 2009
Completion Date
April 16, 2010
Last Updated
October 10, 2023
NCT00033137
NCT07117227
NCT05969496
NCT07123090
NCT06882486
NCT07485114
Lead Sponsor
University of Nebraska
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions